Jay Geller, MD
Dermatology · Chester, NJNPI 1548261266
Payments from drug & device makers
Across 111 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$761
- Sun Pharmaceutical Industries Inc.$239
- Pfizer$207
- Incyte Corporation$175
- Novartis$164
- Sanofi$141
- plus $781 from 18 others
What the payments were for
- Travel & lodging$72629%
- Food & beverage$1,72770%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $761 |
| Sun Pharmaceutical Industries Inc. | 16 | $239 |
| Pfizer | 14 | $207 |
| Incyte Corporation | 10 | $175 |
| Novartis | 9 | $164 |
| Sanofi | 8 | $141 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $110 |
| LEO Pharma Inc. | 7 | $99 |
| Amgen | 6 | $87 |
| AbbVie(2 entities) | 5 | $84 |
| Galderma Laboratories, L.p. | 5 | $79 |
| Botanix SB Inc | 3 | $55 |
| Lilly USA, LLC | 4 | $55 |
| Mayne Pharma Commercial LLC | 3 | $47 |
| Aclaris Therapeutics, Inc. | 2 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $18 |
| UCB, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
| Revance Therapeutics, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Dermira, Inc. | 1 | $13 |
| Almirall LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Chameleon$726
How this compares
$2,468 in reported general payments places this provider in the 50th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 38 | $1,614 |
| Triamcinolone Acetonide | 170 | $1,552 |
| Ketoconazole | 77 | $1,127 |
| Clobetasol Propionate | 13 | $1,045 |
| Metronidazole | 20 | $874 |
| Mupirocin | 89 | $634 |
| Doxycycline Hyclate | 47 | $488 |
| Terbinafine Hcl | 29 | $330 |
| Hydrocortisone | 45 | $261 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chester
- Jerry BagelEast Windsor$15.4M
- Jonathan DosikGlen Rock$8.4M
- Omar NoorSomerset$4.6M
- Linda Cappiello-LindsleyHoboken$2.3M
- Winston MoyDenville$1.8M
- Brian KeeganEast Windsor$1.7M
- Jeanine DownieMontclair$1.2M
- Adolfo Fernandez ObregonHoboken$1.1M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.